ERYTECH Provides Business Update and Reports Financial Results for Full Year 2015 Post author:admERY Post published:February 23, 2016 Post category:Newsroom Conference call and webcast on Wednesday, February 24th at 15:00 pm CET/09:00 am EST You Might Also Like ERYTECH Announces Withdrawal of its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission November 14, 2016 ERYTECH collaborates with Fox Chase Cancer Center to advance its platform in the field of rare metabolic disorders March 23, 2017 ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 September 20, 2021
ERYTECH Announces Withdrawal of its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission November 14, 2016
ERYTECH collaborates with Fox Chase Cancer Center to advance its platform in the field of rare metabolic disorders March 23, 2017
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 September 20, 2021
